Pharmaceutical Executive August 18, 2025
Mike Hollan

Key Takeaways

  • Generative AI automates documentation, reducing manual effort and errors, and acts as a quality control tool by identifying inconsistencies and ensuring document consistency.
  • Google Cloud addresses AI hallucinations with built-in guardrails and organization-specific data, enhancing accuracy and reliability in AI outputs.
  • The regulatory landscape is shifting towards faster feedback cycles with AI, promising quicker access to therapies and reduced revenue loss from drug delays.
  • Organizations must adopt a digital-first strategy, prepare data for AI, and train employees to integrate AI into workflows, transforming regulatory processes and accelerating market access.

The Google Cloud director discusses AI implementation and workflow.

As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article